Ignite Creation Date:
2024-05-06 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05037669
Status:
WITHDRAWN
Last Update Posted:
2023-06-22
First Post:
2021-08-24
Brief Title:
Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor PACE CART19 in Patients With Relapsed Or Refractory CD19 Leukemia and Lymphoma
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2038-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-24
First Submit QC Date:
August 30 2021
Study First Post Date:
2021-09-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-20
Last Update Post Date:
2023-06-22
Last Update Post Date Type:
ACTUAL